SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

 

electronic mail or facsimile during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business day, provided that in either case it is followed promptly by a confirming copy of the notice given via another authorized means for that recipient, (iii) five (5) days after having been sent to a U.S. address by registered or certified mail, return receipt requested, postage prepaid, addressed to the party to be notified at such party’s address as set forth in this section or on Schedule A hereto, or as subsequently modified by written notice, and if to the Company, (iv) two (2) business days after deposit with a nationally recognized overnight courier, freight prepaid for delivery to a U.S. address, specifying next business day delivery, with written verification of receipt, or (v) three (3) business days after deposit with an internationally recognized expedited delivery services company, freight prepaid for deliver to a non-U.S. address, specifying next available business day delivery, with written verification of receipt; provided, however, that notice and other communications given or made to Roche Finance Ltd shall only be provided using the methods set forth in clauses (i), (ii) and (v) above.

 

If to the Company:

AveXis, Inc.

4925 Greenville Avenue, Suite 604

Dallas, Texas 75206

Attn: Sean P. Nolan

Fax:

Email: snolan@AveXisBio.com

 

 

With a simultaneous copy (which shall not constitute notice) to:

Cooley LLP

1114 Avenue of the Americas

New York, NY 10036-7798

Attn: Divakar Gupta

Fax: 1 212 479 6275

Email: dgupta@cooley.com

 

 

If to any T. Rowe Price Investor:

T. Rowe Price Associates, Inc.

100 East Pratt Street

Baltimore, MD 21202

Attn: Andrew Baek, Vice President

Phone: 410-345-2090

E-mail: andrew_baek@troweprice.com

 

Any notice to Roche or Deerfield should be sent to these addresses:

 

If to Roche:

Roche Finance Ltd

Grenzacherstrasse 122

4070 Basel, Switzerland

Fax: + 41 61 687 0644

Attn: Roche Venture Fund, Carole Nuechterlein

 

29



© AveXis, Inc. All Rights Reserved.